MedPath

Investigation of mechanism of acquired chemoresistance for pancreatic cancer

Not Applicable
Recruiting
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000042130
Lead Sponsor
The Jikei University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

Not provided

Exclusion Criteria

N/A

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identification of acquired chemoresistant mutations in chemotherapy
Secondary Outcome Measures
NameTimeMethod
Positive rate of liquid biopsy in pancreatic cancer Success rate of high-precision sequence analysis from minute samples
© Copyright 2025. All Rights Reserved by MedPath